Published in Reprod Biol Endocrinol on February 16, 2011
Tamoxifen and Clomiphene Citrate in Mild Stimulation IVF | NCT02690870
A Higher Ovarian Response after Stimulation for IVF Is Related to a Higher Number of Euploid Embryos. Biomed Res Int (2017) 1.40
The "graying" of infertility services: an impending revolution nobody is ready for. Reprod Biol Endocrinol (2014) 0.88
"Mild" vs. "long" protocol for controlled ovarian hyperstimulation in patients with expected poor ovarian responsiveness undergoing in vitro fertilization (IVF): a large prospective randomized trial. J Assist Reprod Genet (2014) 0.88
MILD ovarian stimulation with GnRH-antagonist vs. long protocol with low dose FSH for non-PCO high responders undergoing IVF: a prospective, randomized study including thawing cycles. J Assist Reprod Genet (2012) 0.80
Advancement in the treatment of diminished ovarian reserve by traditional Chinese and Western medicine. Exp Ther Med (2016) 0.79
Prevention of Ovarian Hyperstimulation Syndrome: A Review. Obstet Gynecol Int (2015) 0.78
Should mild stimulation be the order of the day? J Hum Reprod Sci (2013) 0.78
Efficacy and safety of late-start Corifollitropin-alfa administration for controlled ovarian hyperstimulation in IVF: a cohort, case-control study. J Assist Reprod Genet (2015) 0.75
Metabolite Profiling in the Pursuit of Biomarkers for IVF Outcome: The Case for Metabolomics Studies. Int J Reprod Med (2013) 0.75
Comparison of pregnancy outcome after letrozole versus clomiphene treatment for mild ovarian stimulation protocol in poor responders. Iran J Reprod Med (2014) 0.75
Initial and cyclic recruitment of ovarian follicles. Endocr Rev (2000) 3.76
A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial. Lancet (2007) 3.36
Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr Rev (1996) 3.18
A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol. J Clin Endocrinol Metab (2003) 2.26
Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial. Hum Reprod (2007) 2.11
Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Hum Reprod Update (2006) 1.76
The science behind 25 years of ovarian stimulation for in vitro fertilization. Endocr Rev (2006) 1.75
High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome. Fertil Steril (1996) 1.75
Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocr Rev (1997) 1.75
Less is more: increased gonadotropin use for ovarian stimulation adversely influences clinical pregnancy and live birth after in vitro fertilization. Fertil Steril (2008) 1.64
Gonadotrophin-releasing hormone antagonists for assisted conception. Cochrane Database Syst Rev (2006) 1.60
Clinical management of low ovarian response to stimulation for IVF: a systematic review. Hum Reprod Update (2003) 1.59
GnRH antagonist in assisted reproduction: a Cochrane review. Hum Reprod (2002) 1.54
Optimum number of oocytes for a successful first IVF treatment cycle. Reprod Biomed Online (2006) 1.53
The impact of ovarian stimulation on implantation and fetal development in mice. Hum Reprod (2001) 1.52
How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. Fertil Steril (2008) 1.48
Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks. Hum Reprod (1999) 1.45
Clomiphene citrate: mechanism(s) and site(s) of action--a hypothesis revisited. Fertil Steril (1984) 1.26
The clinical significance of the retrieval of a low number of oocytes following mild ovarian stimulation for IVF: a meta-analysis. Hum Reprod Update (2008) 1.26
Ovarian stimulation and endometrial receptivity. Hum Reprod (1999) 1.24
A prospective, longitudinal study of emotions and relationships in in-vitro fertilization treatment. Hum Reprod (1997) 1.24
Are GnRH antagonists comparable to agonists for use in IVF? Hum Reprod (2007) 1.20
The ISMAAR proposal on terminology for ovarian stimulation for IVF. Hum Reprod (2007) 1.15
Controlled ovarian stimulation induces a functional genomic delay of the endometrium with potential clinical implications. J Clin Endocrinol Metab (2008) 1.13
Will GnRH antagonists provide new hope for patients considered 'difficult responders' to GnRH agonist protocols? Hum Reprod (1999) 1.12
Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment. Hum Reprod (2009) 1.08
The psychological impact of IVF failure after two or more cycles of IVF with a mild versus standard treatment strategy. Hum Reprod (2007) 1.08
Minimal ovarian hyperstimulation for in vitro fertilization using sequential clomiphene citrate and gonadotropin with or without the addition of a gonadotropin-releasing hormone antagonist. Fertil Steril (2002) 1.07
Interventions for 'poor responders' to controlled ovarian hyperstimulation (COH) in in-vitro fertilisation (IVF). Cochrane Database Syst Rev (2007) 1.05
GnRHa to trigger final oocyte maturation: a time to reconsider. Hum Reprod (2009) 1.03
GnRH antagonist improved blastocyst quality and pregnancy outcome after multiple failures of IVF/ICSI-ET with a GnRH agonist protocol. J Assist Reprod Genet (2004) 1.03
Cost-effectiveness of a mild compared with a standard strategy for IVF: a randomized comparison using cumulative term live birth as the primary endpoint. Hum Reprod (2007) 0.98
Increased gonadotrophin stimulation does not improve IVF outcomes in patients with predicted poor ovarian reserve. J Assist Reprod Genet (2008) 0.98
GnRH antagonists in ovarian stimulation: a treatment regimen of clinicians' second choice? Data from the German national IVF registry. Hum Reprod (2005) 0.97
Hopes and facts about mild ovarian stimulation. Reprod Biomed Online (2007) 0.96
Gonadotropin releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles. Cochrane Database Syst Rev (2000) 0.95
Is ovarian stimulation detrimental to the endometrium? Reprod Biomed Online (2007) 0.95
Increasing the human menopausal gonadotropin dose--does the response really improve? Fertil Steril (1990) 0.94
Effect of embryo quality on pregnancy outcome following single embryo transfer in women with a diminished egg reserve. Fertil Steril (2007) 0.91
Comparison of mild stimulation and conventional stimulation in ART outcome. Arch Gynecol Obstet (2009) 0.87
Contemporary pharmacological manipulation in assisted reproduction. Drugs (2004) 0.87
Mild stimulation in in vitro fertilization. Ann N Y Acad Sci (2003) 0.87
Ovulation induction, infertility, and ovarian cancer risk. Fertil Steril (1996) 0.86
Low-dose exogenous FSH initiated during the early, mid or late follicular phase can induce multiple dominant follicle development. Hum Reprod (2001) 0.86
Mild ovarian stimulation. J Assist Reprod Genet (2007) 0.86
Predictors of ongoing pregnancy after single-embryo transfer following mild ovarian stimulation for IVF. Fertil Steril (2007) 0.86
Comparison of outcome of clomiphene citrate/human menopausal gonadotropin/cetrorelix protocol and buserelin long protocol--a randomized study. Gynecol Endocrinol (2006) 0.86
Epidemiology, etiology, and fertility drugs in ovarian epithelial carcinoma: where are we today? Fertil Steril (1994) 0.85
Uterine receptivity and the ramifications of ovarian stimulation on endometrial function. Semin Reprod Med (2007) 0.85
GnRH agonists and antagonists in assisted reproduction: pregnancy rate. Reprod Biomed Online (2006) 0.85
The decrease of serum luteinizing hormone level by a gonadotropin-releasing hormone antagonist following the mild IVF stimulation protocol for IVF and its clinical outcome. J Assist Reprod Genet (2008) 0.84
Predictors of low response to mild ovarian stimulation initiated on cycle day 5 for IVF. Hum Reprod (2007) 0.84
The psychological impact of mild ovarian stimulation combined with single embryo transfer compared with conventional IVF. Hum Reprod (2005) 0.83
GnRH analogues: applications in assisted reproductive techniques. Eur J Endocrinol (2008) 0.83
Mild IVF using GnRH agonist long protocol is possible: comparing stimulations with 100 IU vs. 150 IU recombinant FSH as starting dose. J Assist Reprod Genet (2009) 0.78
Ovarian hyperstimulation can reduce uterine receptivity. A case report. Clin Exp Obstet Gynecol (2000) 0.77
A case report demonstrating that follicle maturing drugs may create an adverse uterine environment even when not used for controlled ovarian hyperstimulation. Clin Exp Obstet Gynecol (2001) 0.77
Follicular fluid content and oocyte quality: from single biochemical markers to metabolomics. Reprod Biol Endocrinol (2009) 1.92
Live birth after orthotopic grafting of autologous cryopreserved ovarian tissue and spontaneous conception in Italy. Fertil Steril (2012) 0.93
Family planning, fertility awareness and knowledge about Italian legislation on assisted reproduction among Italian academic students. Reprod Biomed Online (2010) 0.90
IVF twins have similar obstetric and neonatal outcome as spontaneously conceived twins: a prospective follow-up study. Reprod Biomed Online (2010) 0.90
A retrospective study on IVF outcome in euthyroid patients with anti-thyroid antibodies: effects of levothyroxine, acetyl-salicylic acid and prednisolone adjuvant treatments. Reprod Biol Endocrinol (2009) 0.85
Comparative analysis of fetal and neonatal outcomes of pregnancies from fresh and cryopreserved/thawed oocytes in the same group of patients. Fertil Steril (2013) 0.81
Fertility preservation program before ovarotoxic oncostatic treatments: role of the psychological support in managing emotional aspects. Gynecol Endocrinol (2014) 0.78
Oocyte cryostorage to preserve fertility in oncological patients. Obstet Gynecol Int (2012) 0.78
Slow-freezing-induced changes of birefringent structures in human oocytes are related to responsiveness to ovulation induction. Reprod Biomed Online (2010) 0.77
A critical review of bi-dimensional and three-dimensional ultrasound techniques to monitor follicle growth: do they help improving IVF outcome? Reprod Biol Endocrinol (2014) 0.75
Efficacy and safety of late-start Corifollitropin-alfa administration for controlled ovarian hyperstimulation in IVF: a cohort, case-control study. J Assist Reprod Genet (2015) 0.75
Fertility Preservation Methods in Breast Cancer. Breast Care (Basel) (2012) 0.75
Fertility preservation in BRCA mutation carriers. Minerva Ginecol (2016) 0.75
Superfetation after ovulation induction and intrauterine insemination performed during an unknown ectopic pregnancy. Reprod Biomed Online (2010) 0.75